Study finds cats accepted cultivated hamster cells in wet food: full analysis

A newly published feline feeding study offers an early look at how cultivated meat might perform in a real pet food setting. In Frontiers in Veterinary Science, researchers reported that wet cat food made with cultivated hamster cell biomass was well accepted by most cats and showed digestibility results broadly similar to a chicken-based control, with significantly fewer leftovers on the cultivated diet. (frontiersin.org)

The paper lands as cultivated meat companies keep positioning pet food as a practical entry point for commercialization. That logic is already visible across the sector: pet food companies and startups have argued that companion animal diets could provide an earlier route to market than human food, in part because pet parents may be open to novel proteins and because manufacturers are looking for safe, traceable, consistent meat inputs. Industry coverage this year has also emphasized that scaling and cost, not just technical feasibility, remain the central constraints. (petfoodindustry.com)

In the study itself, 10 healthy adult European shorthair cats took part in a two-day acceptance test, and 8 of those cats moved into a double-blind, cross-over digestibility trial. The control diet used chicken breast meat, while the test diet used cultivated hamster cell biomass as the sole animal-derived ingredient. On a dry matter basis, the cultivated biomass was included at 24.4%, compared with 18.2% chicken in the control formulation. The authors reported comparable nutrient profiles between diets, good overall acceptance, and digestibility values for protein and fat that were close enough to suggest practical nutritional potential, even though protein digestibility differed statistically by a modest 1.4 percentage points. The authors also noted stable body weight and intake patterns over the study periods, alongside stable body and fecal measures. (frontiersin.org)

There are important caveats. The study was small, short, and conducted in healthy research cats, which limits how far the findings can be generalized to broader clinical populations or long-term feeding use. The authors themselves noted that apparent digestibility does not measure protein quality or the bioavailability of indispensable amino acids. They also pointed out formulation differences that could affect intake, including texture and different levels of palatability enhancers between the two diets. Just as importantly, the work was funded by Bene Meat Technologies, the cultivated meat company tied to the ingredient, and the company was involved in study design, article writing, and the decision to submit for publication. (frontiersin.org)

Industry commentary around cultivated meat in pet food helps frame why this matters beyond one paper. In February 2026, Petfood Industry reported that Meatly CEO Owen Ensor described pet food as an especially practical launch market for cultivated meat, while also stressing that the field is still years away from significant market presence. He pointed to cost reductions in culture media and bioreactors, but said the near-term challenge remains proving commercial-scale production at competitive prices. That perspective aligns with the broader cultivated meat landscape: technical promise is one thing, but dependable manufacturing economics and regulatory acceptance will decide whether these ingredients move from pilot stories to routine formulations. (petfoodindustry.com)

Why it matters: For veterinary professionals, this study is useful because it moves the conversation from theory to feeding data in cats, a species where nutritional adequacy is less forgiving than in dogs. Alternative proteins for cats have to do more than satisfy sustainability or ethics goals; they have to support an obligate carnivore’s requirements for nutrients such as taurine, arachidonic acid, and vitamin A through a complete, bioavailable diet. This paper doesn’t answer all of those questions, but it does suggest cultivated animal cells may clear two early hurdles, acceptance and short-term digestibility, better than some skeptics might expect. That could make cultivated ingredients more relevant to future discussions about food safety, supply resilience, and formulation flexibility in feline nutrition. (frontiersin.org)

It may also resonate because cultivated meat has been discussed as a possible way to reduce some upstream risks tied to conventional animal agriculture, including pathogen exposure and supply volatility. Prior commentary in the scientific literature has suggested slaughter-free cell-cultured animal protein could have One Health relevance, including in the context of avian influenza concerns, although those arguments remain broader and more speculative than the cat feeding data in this new paper. For clinicians and nutrition teams, the immediate takeaway is narrower: this is an early proof-of-concept, not a reason to change recommendations today. (frontiersin.org)

What to watch: The next milestones are likely to be longer feeding studies, more complete nutrient bioavailability work, independent replication, and clearer regulatory pathways for cultivated ingredients in pet food. Just as important, watch whether companies can scale production enough to make these proteins commercially relevant rather than scientifically interesting. (petfoodindustry.com)